Overview

Investigational Drug in Patients With Hypercholesterolemia or in Patients With Sitosterolemia (0653-026)(COMPLETED)

Status:
Terminated
Trial end date:
2005-05-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to provide an investigational drug to patients with a specific type of hypercholesterolemia (high cholesterol) or sitosterolemia (unusually high absorption of non-cholesterol sterols) in a treatment use setting.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ezetimibe
Criteria
Inclusion Criteria:

- Homozygous familial hypercholesterolemia or sitosterolemia

Exclusion Criteria:

- Patient has a condition which, in the opinion of the investigator, might pose a risk
to the patient, interfere with participation in the study, or does not meet the
additional criteria as required by the study